MedTrace Logo

AST Clinical Investigation

NCT01268345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2010-12-30

No results posted yet for this study

Summary

Blood glucose monitoring system are tested in the alternative site to validate the accuracy of the blood glucose.

Conditions

Interventions

DEVICE

blood glucose monitor

Blood glucose monitor is used to monitor the blood glucose level of the human-being

DEVICE

blood glucose monitor

Blood glucose monitor is used to monitor the blood glucose level of the human-being.

Sponsors & Collaborators

  • Andon Medical Co.,Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268345 on ClinicalTrials.gov